|
|
| | Segal, D, Tupy, D and Distiller, L The Biosulin equivalence in standard therapy (BEST) study - a multicentre, open-label, non-randomised, interventional, observational study in subjects using Biosulin 30/70 for the treatment of insulin-dependent type 1 and type 2 diabetes mellitus. SAMJ, S. Afr. med. j., July 2013, vol.103, no.7, p.458-460. ISSN 0256-9574
|
|
